1. AstraZeneca Pharma Ind
stock logo

AstraZeneca Pharma Ind Share Price

ASTRAZEN

₹6,379.45-₹59.85 (-0.93%) TodayLast updated on 19 Jun, 2024 | 03:50 PM IST
₹6,302.00₹6,538.95
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹16,146 Crs

Open

₹6,535.90

Close

₹6,439.30

Circuit range

₹7,727.15 - ₹5,151.45

Day range

₹6,302.00 - ₹6,538.95

Year range

₹3,575.00 - ₹7,220.95

Volume

16,938

Avg. traded

₹6,380.65

Revenue (12m)

₹1,296 Crs

AstraZeneca Pharma IndAstraZeneca Pharma India Limited is an India-based biopharmaceutical company. Its therapeutic areas include cardiovascular, renal and metabolism; oncology, and respiratory diseases. The Company operates through Healthcare segment. The Company is engaged in the business of manufacturing, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company. Its therapeutic offerings in CVRM business include heart failure, and chronic kidney disease indications for Forxiga (Dapagliflozin). Its approvals in oncology business include the use of Imfinzi (Durvalumab) in Biliary Tract Carcinoma, and use of Lynparza (Olaparib) in early breast cancer. The Company has a portfolio of oral antidiabetic drugs with presence in two drug classes: SGLT2 inhibitors and DPP4 inhibitors. The Company’s DPP4 offering comprises of the brands of Onglyza (Saxagliptin) and Kombiglzye (Saxagliptin/Metformin).

AstraZeneca Pharma Ind Key indicators

arrow

52 week high

₹7,220.95

52 week low

₹3,575.00

P/E ratio

99.98

P/B ratio

22.68

ROE

18.13%

ROCE

24.49%

Dividend yield

0.37%

Debt/Equity ratio

EPS

39.72

Learn more

Investment checklist: (5/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

18.98%

Net profit margin

9.85%

ROE

18.13%

ROA

9.37%

ROCE

24.49%

Learn more

AstraZeneca Pharma Ind Shareholder returns

arrow

1 day

+1.34%

1 week

+3.25%

1 month

+18.35%

3 months

+31.06%

1 year

+76.83%

3 years

+69.36%

5 years

+241.03%

AstraZeneca Pharma Ind Share Price history

arrow
DayOpenCloseDay’s change
Tue, Jun 18 2024
₹6,549.00
₹6,439.30
-0.30%
Fri, Jun 14 2024
₹6,320.00
₹6,458.55
+1.34%
Thu, Jun 13 2024
₹6,349.80
₹6,373.40
+0.49%
Wed, Jun 12 2024
₹6,399.00
₹6,342.50
+0.15%
Tue, Jun 11 2024
₹6,239.80
₹6,332.85
+1.63%
Mon, Jun 10 2024
₹6,306.40
₹6,231.00
-0.39%
Fri, Jun 7 2024
₹6,200.00
₹6,255.45
+0.81%
Thu, Jun 6 2024
₹6,048.00
₹6,205.15
+3.21%

Shareholding info

arrow

Promoters (75%)

Mutual Funds (3.75%)

Retail and other (18.49%)

Foreign institutions-FII (2.73%)

Other domestic institutions (0.02%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹16/share

    Ex date 14 Jul 2023

    expand tab
  • Dividend • ₹8/share

    Ex date 07 Jul 2022

    expand tab

Learn more

Frequently asked questions